SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-24-007083
Filing Date
2024-05-30
Accepted
2024-05-30 17:04:14
Documents
16
Period of Report
2024-05-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K edsa_8k.htm   iXBRL 8-K 54743
2 AMENDMENT NO. 3 edsa_ex101.htm EX-10.1 9521
  Complete submission text file 0001654954-24-007083.txt   188801

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA edsa-20240530.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20240530_lab.xml EX-101.LAB 14059
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20240530_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20240530_pre.xml EX-101.PRE 8880
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20240530_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT edsa_8k_htm.xml XML 3711
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 241006396
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)